165 related articles for article (PubMed ID: 28793338)
1. Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5.
Fang X; Xie H; Duan H; Li P; Yousaf M; Xu H; Yang Y; Wang C
PLoS One; 2017; 12(8):e0182697. PubMed ID: 28793338
[TBL] [Abstract][Full Text] [Related]
2. Enhanced lymphatic delivery of nanomicelles encapsulating CXCR4-recognizing peptide and doxorubicin for the treatment of breast cancer.
Fang X; Zhang K; Jiang M; Ma L; Liu J; Xu H; Yang Y; Wang C
Int J Pharm; 2021 Feb; 594():120183. PubMed ID: 33340596
[TBL] [Abstract][Full Text] [Related]
3. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
[TBL] [Abstract][Full Text] [Related]
5. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin.
Tang N; Du G; Wang N; Liu C; Hang H; Liang W
J Natl Cancer Inst; 2007 Jul; 99(13):1004-15. PubMed ID: 17596572
[TBL] [Abstract][Full Text] [Related]
6. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
7. Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression.
Guo H; Ge Y; Li X; Yang Y; Meng J; Liu J; Wang C; Xu H
Signal Transduct Target Ther; 2017; 2():17033. PubMed ID: 29263923
[TBL] [Abstract][Full Text] [Related]
8. Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia.
Zhang M; Ge Y; Xu S; Fang X; Meng J; Yu L; Wang C; Liu J; Wen T; Yang Y; Wang C; Xu H
Pharmacol Res; 2022 Nov; 185():106503. PubMed ID: 36241000
[TBL] [Abstract][Full Text] [Related]
9. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
[TBL] [Abstract][Full Text] [Related]
10. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells.
Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460
[TBL] [Abstract][Full Text] [Related]
11. Synthetic CXCR4 Antagonistic Peptide Assembling with Nanoscaled Micelles Combat Acute Myeloid Leukemia.
Meng J; Ge Y; Xing H; Wei H; Xu S; Liu J; Yan D; Wen T; Wang M; Fang X; Ma L; Yang Y; Wang C; Wang J; Xu H
Small; 2020 Aug; 16(31):e2001890. PubMed ID: 32608185
[TBL] [Abstract][Full Text] [Related]
12. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
13. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
15. A novel micelle of coumarin derivative monoend-functionalized PEG for anti-tumor drug delivery: in vitro and in vivo study.
Lai Y; Long Y; Lei Y; Deng X; He B; Sheng M; Li M; Gu Z
J Drug Target; 2012 Apr; 20(3):246-54. PubMed ID: 22118403
[TBL] [Abstract][Full Text] [Related]
16. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
Xu M; Qian J; Liu X; Liu T; Wang H
Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
[TBL] [Abstract][Full Text] [Related]
17. Reduction-responsive disassemblable core-cross-linked micelles based on poly(ethylene glycol)-b-poly(N-2-hydroxypropyl methacrylamide)-lipoic acid conjugates for triggered intracellular anticancer drug release.
Wei R; Cheng L; Zheng M; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2012 Aug; 13(8):2429-38. PubMed ID: 22746534
[TBL] [Abstract][Full Text] [Related]
18. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
19. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
20. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]